Skip to main content
ALT logo
ALT
(NASDAQ)
Altimmune, Inc.
$2.84-- (--)
Loading... - Market loading

Altimmune (ALT) Stock Price & Financial Analysis

Altimmune Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$2.75 - $2.84
52-Week High$6.44
52-Week Low$2.56
Open$2.79
Volume1.63M
Average Volume (3M)4.17M
Market Cap353.47M
Shares Outstanding124.46M
Price to Sales (P/S)9818.65
Price to Book (P/B)1.24
EV/EBITDA-3.27
Revenue (TTM)36.00K
Net Income (TTM)-91.08M
Free Cash Flow (TTM)-71.67M
EPS (TTM)$-0.92
Profit Margin-253002.78%
Operating Margin-269216.67%
Return on Equity (ROE)-32.07%
Debt to Equity0.13
50-Day MA$2.89
200-Day MA$3.80
52-Week Change-33.80%
Annual Dividend$0.00
Dividend Yield0.00%
Last Dividend Ex-DateFeb 6, 2017

Frequently Asked Questions About Altimmune

What is the current stock price for ALT?

As of the latest trading session, ALT stock trades at $2.84. The 52-week range is $2.56–$6.44, with a day range of $2.75–$2.84.

What is the P/E ratio for ALT?

The P/E ratio (Price-to-Earnings) for ALT is shown in the Key Statistics section. This valuation metric helps compare Altimmune, Inc. to industry peers.

Does ALT pay dividends?

Altimmune does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ALT?

Based on 8 analysts, the consensus for ALT is Buy.

What is the market cap of ALT?

Altimmune's market capitalization is $353.5M, classifying it as a small-cap company. Altimmune operates in the Healthcare sector within the Biotechnology industry.